No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Pitfalls of tungsten multileaf collimator in proton beam therapy
3. C. W. Cheng, I. J. Das, and T. Steinberg, “Role of multileaf collimator in replacing shielding blocks in radiation therapy,” Int. J. Cancer 96, 385–395 (2001).
4. E. E. Klein, W. B. Harms, D. A. Low, V. Willcut, and J. A. Purdy, “Clinical implementation of a commercial multileaf collimator: Dosimetry, networking, simulation, and quality assurance,” Int. J. Radiat. Oncol., Biol., Phys. 33, 1195–1208 (1995).
5. D. Georg, F. Julia, E. Briot, D. Huyskens, U. Wolff, and A. Dutreix, “Dosimetric comparison of an integrated multileaf-collimator versus a conventional collimator,” Phys. Med. Biol. 42, 2285–2303 (1997).
7. I. J. Das, G. E. Desobry, S. W. McNeeley, E. C. Cheng, and T. E. Schultheiss, “Beam characteristics of a retrofitted double-focused multileaf collimator,” Med. Phys. 25, 1676–1684 (1998).
8. A. L. Boyer, T. G. Ochran, C. E. Nyerick, T. J. Waldron, and C. J. Huntzinger, “Clinical dosimetry for implementation of a multileaf collimator,” Med. Phys. 19, 1255–1261 (1992).
9. I. J. Das, C. W. Cheng, K. L. Chopra, R. K. Mitra, S. P. Srivastava, and E. Glatstein, “Intensity-modulated radiation therapy dose prescription, recording, and delivery: Patterns of variability among institutions and treatment planning systems,” J. Natl. Cancer Inst. 100, 300–307 (2008).
14. T. L. Huang, W. L. Tsai, C. Y. Chien, T. F. Lee, and F. M. Fang, “Quality of life for head and neck cancer patients treated by combined modality therapy: The therapeutic benefit of technological advances in radiotherapy,” Qual. Life Res. 19, 1243–1254 (2010).
15. B. R. Paliwal, I. A. Brezovich, and W. R. Hendee, “IMRT may be used to excess because of its higher reimbursement from medicare,” Med. Phys. 31, 1–3 (2004).
18. A. Peeters, J. P. C. Grutters, M. Pijls-Johannesma, S. Reimoser, D. De Ruysscher, J. L. Severens, M. A. Joore, and P. Lambin, “How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons,” Radiother. Oncol. 95, 45–53 (2010).
21. R. L. Maughan, M. Yudelev, J. D. Forman, S. B. Williams, D. Gries, T. M. Fletcher, W. Chapman, E. J. Blosser, and T. Horste, “Attenuation and activation characteristics of steel and tungsten and the suitability of these materials for use in a fast neutron multileaf collimator,” Med. Phys. 28, 1006–1009 (2001).
22. J. B. Farr, R. L. Maughan, M. Yudelev, E. Blosser, J. Brandon, T. Horste, and J. D. Forman, “Compact multileaf collimator for conformal and intensity modulated fast neutron therapy: Electromechanical design and validation,” Med. Phys. 33, 3313–3320 (2006).
23. M. Torikoshi, S. Minohara, N. Kanematsu, M. Komori, M. Kanazawa, K. Noda, N. Miyahara, H. Itoh, M. Endo, and T. Kanai, “Irradiation system for HIMAC,” J. Radiat. Res. 48, A15–A25 (2007).
24. J. Daartz, M. Bangert, M. R. Bussiere, M. Engelsman, and H. M. Kooy, “Characterization of a mini-multileaf collimator in a proton beamline,” Med. Phys. 36, 1886–1894 (2009).
25. M. Bues, W. D. Newhauser, U. Titt, and A. R. Smith, “Therapeutic step and shoot proton beam spot-scanning with a multi-leaf collimator: A Monte Carlo study,” Radiat. Prot. Dosim. 115, 164–169 (2005).
26. I. Das, T. Akagi, K. Kagawa, H. Mayahara, T. Yanou, D. Suga, H. Sakamoto, Y. Hishigawa, and M. Abe, “Geometric and dosimetric characteristics of a proton beam multileaf collimator (MLC),” Med. Phys. 31, 1797–1797 (2004).
27. S. A. Maloy, W. F. Sommer, M. R. James, T. J. Romero, M. R. Lopez, E. Zimmermann, and J. M. Ledbetter, “The accelerator production of tritium materials test program,” Nucl. Technol. 132, 103–114 (2000).
28. C. H. Pyeon, T. Misawa, J. Y. Lim, H. Unesaki, Y. Ishi, Y. Kuriyama, T. Uesugi, Y. Mori, M. Inoue, K. Nakajima, K. Mishima, and S. Shiroya, “First injection of spallation neutrons generated by high-energy protons into the Kyoto University Critical Assembly,” J. Nucl. Sci. Technol. 46, 1091–1093 (2009).
29. Y. V. Ryabov, M. I. Grachev, D. V. Kamanin, E. A. Kuznetsova, V. L. Kuznetsov, E. A. Koptelov, O. N. Libanova, V. S. Litvin, V. N. Matushko, V. I. Razin, R. A. Sadykov, N. M. Sobolevskii, and V. A. Fedchenko, “A pulsed neutron source on the proton beam for the Moscow Meson Factory,” Phys. Solid State 52, 1021–1024 (2010).
30. J. Wei, S. N. Fu, J. Y. Tang, J. Z. Tao, D. S. Wang, F. W. Wang, and S. Wang, “China spallation neutron source—An overview of application prospects,” Chinese Phys. C 33, 1033–1042 (2009).
31. D. J. Brenner, C. D. Elliston, E. J. Hall, and H. Paganetti, “Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator,” Phys. Med. Biol. 54, 6065–6078 (2009).
32. P. J. Taddei, J. D. Fontenot, Y. Zheng, D. Mirkovic, A. K. Lee, U. Titt, and W. D. Newhauser, “Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer,” Phys. Med. Biol. 53, 2131–2147 (2008).
33. P. J. Taddei, D. Mirkovic, J. D. Fontenot, A. Giebeler, Y. S. Zheng, U. Titt, S. A. Woo, and W. D. Newhauser, “Reducing stray radiation dose for a pediatric patient receiving proton craniospinal irradiation,” Nucl. Technol. 168, 108–112 (2009).
38. A. Ferrari, P. R. Sala, A. Fasso, and J. Ranft, “FLUKA: A multi-particle transport code,” CERN 2005-10, INFN/TC_05/11, SLAC-R-773 (2005).
39. G. Battistoni, S. Muraro, P. R. Sala, F. Cerutti, A. Ferrari, S. Roesler, A. Fasso, and J. Ranft, “The FLUKA code: Description and benchmarking,” in Proceedings of the Hadronic Shower Simulation Workshop 2006, edited by M. Albrow and R. Raja, 6–8 September (Fermilab, 2006), AIP Conf. Proc. 896, 31–49 (2007).
40. J. M. Bauer, V. Bharadwaj, H. Brogonia, M. Brugger, M. Kerimbaev, J. C. Liu, S. Mallows, A. A. Prinz, S. Roesler, S. H. Rokni, T. Sanami, M. Santana-Leitner, J. Sheppard, H. Vincke, and J. Vollaire, “Benchmark study of induced radioactivity at a high-energy electron accelerator,” Nucl. Technol. 168, 648–653 (2009).
41. M. Brugger, D. Forkel-Wirth, and S. Roesler, “Generic studies of radioactivity induced by high-energy beams in different absorber materials,” Nucl. Technol. 168, 665–669 (2009).
42. M. Brugger, A. Ferrari, S. Roesler, and L. Ulrici, “Validation of the FLUKA Monte Carlo code for predicting induced radioactivity at high-energy accelerators,” Nucl. Instrum. Meth. A 562, 814–818 (2006).
43. S. Roesler and G. R. Stevenson, “deq99.f—A FLUKA user-routine converting fluence into effective dose and ambient dose equivalent,” Technical Note CERN-SC-2006-070-RP-TN EDMS No. 809389 (2006).
44. ICRP, Conversion Coefficients for Use in Radiological Protection Against External Radiation, ICRP Publication 74 (Pergamon, Oxford, 1996).
45. M. Pelliccioni, “Overview of fluence-to-effective dose and fluence-to ambient dose equivalent conversion coefficients for high energy radiation calculated using the FLUKA code,” Radiat. Prot. Dosim. 88, 279–297 (2000).
47. J. B. Farr, A. E. Mascia, W. C. Hsi, C. E. Allgower, F. Jesseph, A. N. Schreuder, M. Wolanski, D. F. Nichiporov, and V. Anferov, “Clinical characterization of a proton beam continuous uniform scanning system with dose layer stacking,” Med. Phys. 35, 4945–4954 (2008).
48. A. Cesana, E. Mauro, and M. Silari, “Induced radioactivity in a patient-specific collimator used in proton therapy,” Nucl. Instrum. Methods Phys. Res. B 268, 2272–2280 (2010).
49. X. G. Xu, B. Bednarz, and H. Paganetti, “A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction,” Phys. Med. Biol. 53, R193–R241 (2008).
50. M. Stovall, C. R. Blackwell, J. Cundiff, D. H. Novack, J. R. Palta, L. K. Wagner, E. W. Webster, and R. J. Shalek, “Fetal dose from radiotherapy with photon beams—Report Of AAPM radiation-therapy committee task Group NO-36,” Med. Phys. 22, 1353–1354 (1995).
51. S. F. Kry, M. Salehpour, D. S. Followill, M. Stovall, D. A. Kuban, R. A. White, and I. I. Rosen, “The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 62, 1195–1203 (2005).
52. D. S. Followill, M. S. Stovall, S. F. Kry, and G. S. Ibbott, “Neutron source strength measurements for Varian, Siemens, Elekta, and General Electric linear accelerators,” J. Appl. Clin. Med. Phys. 4, 189–194 (2003).
54. S. F. Kry, M. Salehpour, D. S. Followill, M. Stovall, D. A. Kuban, R. A. White, and I. I. Rosen, “Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 62, 1204–1216 (2005).
55. S. F. Kry, D. Followfll, R. A. White, M. Stovall, D. A. Kuban, and M. Salehpour, “Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 68, 1265–1271 (2007).
56. W. D. Newhauser, J. D. Fontenot, A. Mahajan, D. Kornguth, M. Stovall, Y. S. Zheng, P. J. Taddei, D. Mirkovic, R. Mohan, J. D. Cox, and S. Woo, “The risk of developing a second cancer after receiving craniospinal proton irradiation,” Phys. Med. Biol. 54, 2277–2291 (2009).
57. C. Z. Jarlskog and H. Paganetti, “Risk of developing second cancer from neutron dose in proton therapy as function of field characteristics, organ, and patient age,” Int. J. Radiat. Oncol., Biol., Phys. 72, 228–235 (2008).
58. B. S. Athar and H. Paganetti, “Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plans,” Radiother. Oncol. 98, 87–92 (2011).
59. ICRP, Recommendations of the International Commission on Radiological Protection, ICRP Publication 60 (Pergamon, Oxford, 1990).
60. ICRP, The 2007 Recommendations of the International Commission on Radiological Protection ICRP Publication 103 (Pergamon, Oxford, 2007).
61. N. W. Hengartner, B. E. Takala, S. E. Michalak, and S. A. Wender, “Evaluating experiments for estimating the bit failure cross-section of semiconductors using a colored spectrum neutron beam,” Technometrics 50, 8–14 (2008).
62. H. H. K. Tang and K. P. Rodbell, “Single-event upsets in microelectronics: Fundamental physics and issues,” MRS Bull. 28, 111–116 (2003).
65. C. Dyer, A. Hands, K. Ford, A. Frydland, and P. Truscott, “Neutron-induced single event effects testing across a wide range of energies and facilities and implications for standards,” IEEE Trans. Nucl. Sci. 53, 3596–3601 (2006).
66. S. F. Kry, J. L. Johnson, R. A. White, R. M. Howell, R. J. Kudchadker, and M. T. Gillin, “Neutron-induced electronic failures around a high-energy linear accelerator,” Med. Phys. 38, 34–39 (2011).
67. J. D. Wilkinson, C. Bounds, T. Brown, B. J. Gerbi, and J. Peltier, “Cancer-radiotherapy equipment as a cause of soft errors in electronic equipment,” IEEE Trans. Device Mater. Reliab. 5, 449–451 (2005).
71. T. Otsuka, T. Hoshihira, and T. Tanabe, “Visualization of hydrogen depth profile by means of tritium imaging plate technique: Determination of hydrogen diffusion coefficient in pure tungsten,” Phys. Scr. T138, 014052 (2009).
Article metrics loading...
Full text loading...
Most read this month